Loading
A phase 2 trial in triple-negative breast cancer, run by Fudan University, now recruiting.
BrAin Metastasis in tripLe Negateive Breast Cancer: IvoneScimab and Trop2 ADC is a phase 2, interventional study registered as NCT06793332 by Fudan University, with a registry enrolment figure of 39 participants, started 2024-12-17 and due to reach its primary completion in 2026-01-31. Interventions recorded: Ivonescimab Combined With TROP2 ADC. Conditions listed: Triple-Negative Breast Cancer (TNBC); Brain Metastases. Triple-negative eligibility wording from the registry: "Patients with unresectable locally advanced, recurrent or metastatic triple-negative breast cancer who have failed treatment with taxane drugs are included". Sites: China. No results are recorded here; the registry entry is the source.
Shares Brain metastases (intracranial disease), Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.
Shares Metastatic triple-negative breast cancer, Early triple-negative breast cancer, Triple-negative breast cancer trials open today (registry snapshot and UK sites) and the tag tnbc-deep-dive.